CRISPR Therapeutics AGEquity-NMS: CRSP
Equity-NMS: CRSP
$57.96
-0.76
(16 Apr)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$57.96
Open
$57.96
Today’s high
$58.74
Today’s low
$57.14
52W low
$37.55
52W high
$91.1
1Y
15.07%
5Y
8.19%
PE
-32.45
EPS (TTM)
-1.94
Shares O/S
84.88M
Market cap
4.92B
Insights
CRSP price is above its 200 day moving average
CRSP PE is in the top end of its range over the past 2 years
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About CRISPR Therapeutics AG

CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA.

The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates. .


FAQs

Can I buy CRISPR Therapeutics AG shares in India?
How to buy CRISPR Therapeutics AG shares in India?
What is the share price of CRISPR Therapeutics AG?
What is the Market Capitalization of CRISPR Therapeutics AG?
What is the PE ratio of CRISPR Therapeutics AG?
Is CRISPR Therapeutics AG a good stock to buy?
In which sector / industry does CRISPR Therapeutics AG operate?